News & Updates

Show Multimedia Only

Multimodal AI system improves accuracy in identifying interstitial pneumonia

19 Sep 2025 by

The multimodal artificial intelligence (AI) algorithm that combines computed tomography (CT) and histopathological images improves diagnostic accuracy, consistency, and confidence of pathologists in identifying usual interstitial pneumonia (UIP) in patients with resected lung specimens, reports a study.

Multimodal AI system improves accuracy in identifying interstitial pneumonia

19 Sep 2025

Adults with severe asthma may safely perform 6-min walk test

17 Sep 2025

The 6-min walk test appears to be safe for adult patients with severe asthma provided that they receive a bronchodilator medication prior to the test and stop once the blood oxygen saturation levels drop below 85 percent, according to a study.

Adults with severe asthma may safely perform 6-min walk test

17 Sep 2025

Admilparant shows promise in idiopathic, progressive pulmonary fibrosis

17 Sep 2025

The investigational oral lysophosphatidic acid receptor 1 antagonist admilparant helps delay disease progression in patients with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis, according to a phase II trial.

Admilparant shows promise in idiopathic, progressive pulmonary fibrosis

17 Sep 2025

Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis

16 Sep 2025 by

In patients with suspected sarcoidosis, small airway biopsy (SAB) guided by ultrathin bronchoscopy (UTB) shows promise for increasing the detection rate of granulomatous inflammation while minimizing the risk of pneumothorax associated with transbronchial lung biopsy (TBLB).

Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis

16 Sep 2025

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

14 Sep 2025

In patients with severe eosinophilic asthma, treatment with mepolizumab reduces exposure to toxic levels of oral corticosteroids (OCS) and, in turn, the incidence of associated complications, according to a real-world study.

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

14 Sep 2025

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

08 Sep 2025 by

The use of the antihistamine nasal spray azelastine may help prevent SARS-CoV-2 respiratory infections, as shown in a phase II study.

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

08 Sep 2025

Pembrolizumab prolongs real-world survival in NSCLC patients

01 Sep 2025

Treatment with pembrolizumab demonstrates effectiveness in improving progression-free survival (PFS) and overall survival (OS) in real clinical practice, results of a study have shown.

Pembrolizumab prolongs real-world survival in NSCLC patients

01 Sep 2025

Respiratory virus ups mortality risk in kids undergoing LT

01 Sep 2025

Detection of respiratory viruses in children with severe hepatocellular dysfunction during the peri-liver transplant period appears to increase the risk of death and postoperative surgical complications, reveals a recent study.

Respiratory virus ups mortality risk in kids undergoing LT

01 Sep 2025

7,000 steps a day may be enough

29 Aug 2025 by

Walking 7,000 steps a day can offer the same health benefits as walking 10,000 steps a day, according to a comprehensive review and meta-analysis. Experts said it could be a more realistic target than the 10,000 steps, which is traditionally seen as the benchmark to reach.

7,000 steps a day may be enough

29 Aug 2025

Should O2 exposure be reduced in critically ill patients on MV, O2?

28 Aug 2025 by

Findings from the UK-ROX* trial do not support reducing oxygen (O2) exposure by targeting a peripheral O2 saturation (SpO2) of 90 percent in adult patients receiving mechanical ventilation (MV) and supplemental O2 in the intensive care unit (ICU).

Should O2 exposure be reduced in critically ill patients on MV, O2?

28 Aug 2025

News & Updates

Filter by Specialty:

Specialty:

Multimodal AI system improves accuracy in identifying interstitial pneumonia

Multimodal AI system improves accuracy in identifying interstitial pneumonia

Adults with severe asthma may safely perform 6-min walk test

Adults with severe asthma may safely perform 6-min walk test

Admilparant shows promise in idiopathic, progressive pulmonary fibrosis

Admilparant shows promise in idiopathic, progressive pulmonary fibrosis

Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis

Ultrathin bronchoscopy boosts small airway biopsy potential for diagnosing sarcoidosis

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

Mepolizumab cuts exposure to OCS in severe eosinophilic asthma

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

Antihistamine nasal spray a promising prophylactic treatment against SARS-CoV-2

Pembrolizumab prolongs real-world survival in NSCLC patients

Pembrolizumab prolongs real-world survival in NSCLC patients

Respiratory virus ups mortality risk in kids undergoing LT

Respiratory virus ups mortality risk in kids undergoing LT

7,000 steps a day may be enough

7,000 steps a day may be enough

Should O2 exposure be reduced in critically ill patients on MV, O2?

Should O2 exposure be reduced in critically ill patients on MV, O2?